These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9151135

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of adult oligodendrocytes in remyelination after neural injury.
    Vick RS, Neuberger TJ, DeVries GH.
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S93-103. PubMed ID: 1588636
    [Abstract] [Full Text] [Related]

  • 6. The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes.
    Blakemore WF.
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):1-10. PubMed ID: 15634226
    [Abstract] [Full Text] [Related]

  • 7. Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination.
    Miller DJ, Rodriguez M.
    Microsc Res Tech; 1995 Oct 15; 32(3):230-45. PubMed ID: 8527857
    [Abstract] [Full Text] [Related]

  • 8. The cellular and molecular events of central nervous system remyelination.
    Dubois-Dalcq M, Armstrong R.
    Bioessays; 1990 Dec 15; 12(12):569-76. PubMed ID: 2080911
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Remyelination in multiple sclerosis: a new role for neurotrophins?
    Althaus HH.
    Prog Brain Res; 2004 Dec 15; 146():415-32. PubMed ID: 14699977
    [Abstract] [Full Text] [Related]

  • 14. The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders.
    Pluchino S, Martino G.
    J Neurol Sci; 2005 Jun 15; 233(1-2):117-9. PubMed ID: 15896808
    [Abstract] [Full Text] [Related]

  • 15. Cellular remyelinating therapy in multiple sclerosis.
    Yang J, Rostami A, Zhang GX.
    J Neurol Sci; 2009 Jan 15; 276(1-2):1-5. PubMed ID: 18814888
    [Abstract] [Full Text] [Related]

  • 16. Enhancing central nervous system remyelination in multiple sclerosis.
    Dubois-Dalcq M, Ffrench-Constant C, Franklin RJ.
    Neuron; 2005 Oct 06; 48(1):9-12. PubMed ID: 16202704
    [Abstract] [Full Text] [Related]

  • 17. Understanding CNS remyelination: clues from developmental and regeneration biology.
    Franklin RJ, Hinks GL.
    J Neurosci Res; 1999 Oct 15; 58(2):207-13. PubMed ID: 10502277
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity of pathogenesis in multiple sclerosis: implications for promotion of remyelination.
    Paz Soldan MM, Rodriguez M.
    J Infect Dis; 2002 Dec 01; 186 Suppl 2():S248-53. PubMed ID: 12424705
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Spontaneous central nervous system remyelination is not altered in NFH-lacZ transgenic mice after chemical demyelination.
    Jean I, Fressinaud C.
    J Neurosci Res; 2003 Jul 01; 73(1):54-60. PubMed ID: 12815708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.